Related Experiment Videos
[Pemphigoid gestationis: a study of 20 cases]
1Service de Dermatologie, Hôpital La Rabta, Tunis, Tunisie. mourad.mokni@ns.tn
Annales De Dermatologie Et De Venereologie
|December 17, 2004
Summary
Pemphigoid gestationis, a pregnancy-related autoimmune skin condition, often presents late in pregnancy. Topical corticosteroids are effective treatments, with unique patient profiles observed in Tunisia.
Area of Science:
- Dermatology
- Immunology
- Obstetrics
Context:
- Pemphigoid gestationis (PG) is a rare, autoimmune blistering disease specific to pregnancy.
- Understanding the epidemiological and clinical characteristics of PG is crucial for patient management.
Purpose:
- To define the epidemio-clinical profile, histopathological and immunopathological features, treatment, and course of pemphigoid gestationis in Tunisian patients.
Summary:
- A retrospective study of 20 Tunisian patients with PG revealed a late onset (3rd trimester) in 60% of cases.
- Clinical manifestations included urticarial patches (90%) and blisters (65%), predominantly on the trunk and limbs.
- Histopathology showed sub-epidermal blisters and immune findings consistent with complement deposition along the basement membrane zone.
Impact:
- The study highlights specific clinical features of PG in Tunisia, including frequent facial and mucosal involvement.
- It confirms the efficacy of topical class I corticosteroids for PG treatment.
- The observed fetal outcomes suggest a lower risk of prematurity and hypotrophy compared to literature, though other adverse outcomes were noted.